Searched for
GLAXOSMITHKLINE PHARMACEUTICALS INDIA
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- GSK's Calpol a well-known trademark: High CourtThe Delhi High Court has recognized GlaxoSmithKline Pharmaceuticals' pain and fever medicine, Calpol, as a well-known trademark. This desig...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...
- I-Sec upgrades GlaxoSmithKline Pharma to Add, lowers target price to Rs 2,250ICICI Securities has raised its rating on GlaxoSmithKline Pharmaceuticals to Add from Hold with a new target price of Rs 2250. GSK Pharma's...
- CCI approves Corona Remedies-GlaxoSmithKline dealDilo-BM, Dilo-DX, Stelbid and Vitneurin brands of GlaxoSmithKline would be acquired by Corona Remedies along with trademark and goodwill.
- GlaxoSmithKline Pharma Q2 net dips 25 per cent at Rs 96 croreThe company had posted a net profit of Rs 128.67 crore for the same period a year ago, GlaxoSmithKline Pharmaceuticals said in a filing to ...
- GSK Pharma completes deal with Novartis HealthcareDrug firm GlaxoSmithKline Pharmaceuticals has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis...
- GSK Pharma to transfer cancer drug portfolio to Novartis armGlaxoSmithKline Pharmaceuticals board approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquirin...
- GSK raises India unit stake to 75% via open offerWe are very pleased with the outcome of this transaction, which further increases our exposure to a strategically important market," GSK Ch...
- FIPB clears GlaxoSmithKline's Rs 6,400 cr FDI proposalFIPB today cleared Rs 6,400 crore FDI proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm.
- GSK's open offer for buying stake in Indian arm from February 7-21GlaxoSmithKline Plc's Rs 6,389.02 crore open offer to pick up 24.33 per cent stake in its Indian arm GlaxoSmithKline Pharma will start from...
- GlaxoSmithKline Pharma Q1 net up 37.52 per cent at Rs 169 croreGlaxoSmithKline Pharmaceuticals today reported a 37.52 per cent rise in its net profit to Rs 169.01 crore for the first quarter ended March...
- Morgan Stanley cuts GlaxoSmithKline Pharma to 'under-weight'Morgan Stanley cut its rating on GSK Pharma to "under-weight", citing expectations the drug maker will post modest growth.
- GlaxoSmithKline net up 18 pc at Rs 136.74 croreGlaxoSmithKline Pharmaceuticals said its net profit rose by 18.18 per cent to Rs 136.74 crore for the quarter ended December 31, 2011.
- GlaxoSmithKline Pharma to launch more vaccines in IndiaDrug major GlaxoSmithKline Pharmaceuticals on MOnday said it would be launching more vaccines in the Indian market.
- FDA raids fake thyroid drug makers in MumbaiThe State Food and Drug Administration (FDA) intelligence wing has conducted raids on manufacturers of spurious thyroid drugs and is lookin...
Load More
